GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $519,000 | -56.0% | 11,934 | -56.0% | 0.11% | -49.3% |
| Q1 2022 | $1,180,000 | +623.9% | 27,096 | +633.1% | 0.22% | +596.9% |
| Q4 2021 | $163,000 | -1.8% | 3,696 | -15.2% | 0.03% | -15.8% |
| Q3 2021 | $166,000 | -13.1% | 4,357 | -9.3% | 0.04% | -13.6% |
| Q2 2021 | $191,000 | +29.9% | 4,805 | +16.8% | 0.04% | +15.8% |
| Q1 2021 | $147,000 | +5.8% | 4,114 | +8.7% | 0.04% | -5.0% |
| Q4 2020 | $139,000 | -26.1% | 3,784 | -24.1% | 0.04% | -33.3% |
| Q3 2020 | $188,000 | +88.0% | 4,984 | +102.9% | 0.06% | +71.4% |
| Q2 2020 | $100,000 | -13.0% | 2,456 | 0.0% | 0.04% | -14.6% |
| Q1 2020 | $115,000 | 0.0% | 2,456 | 0.0% | 0.04% | +2.5% |
| Q4 2019 | $115,000 | +5.5% | 2,456 | -4.1% | 0.04% | -2.4% |
| Q3 2019 | $109,000 | +6.9% | 2,561 | 0.0% | 0.04% | +5.1% |
| Q2 2019 | $102,000 | -4.7% | 2,561 | 0.0% | 0.04% | -11.4% |
| Q1 2019 | $107,000 | +9.2% | 2,561 | 0.0% | 0.04% | -4.3% |
| Q4 2018 | $98,000 | -4.9% | 2,561 | 0.0% | 0.05% | +7.0% |
| Q3 2018 | $103,000 | +4.0% | 2,561 | +4.3% | 0.04% | -2.3% |
| Q2 2018 | $99,000 | +1.0% | 2,456 | -2.5% | 0.04% | +10.0% |
| Q1 2018 | $98,000 | -14.0% | 2,520 | -21.7% | 0.04% | -11.1% |
| Q4 2017 | $114,000 | -13.0% | 3,220 | 0.0% | 0.04% | -18.2% |
| Q3 2017 | $131,000 | -2.2% | 3,220 | +3.2% | 0.06% | -9.8% |
| Q2 2017 | $134,000 | +2.3% | 3,119 | 0.0% | 0.06% | -1.6% |
| Q1 2017 | $131,000 | +9.2% | 3,119 | 0.0% | 0.06% | +5.1% |
| Q4 2016 | $120,000 | -11.1% | 3,119 | 0.0% | 0.06% | -11.9% |
| Q3 2016 | $135,000 | -0.7% | 3,119 | -0.4% | 0.07% | -4.3% |
| Q2 2016 | $136,000 | -9.9% | 3,133 | -15.8% | 0.07% | -16.7% |
| Q1 2016 | $151,000 | -1.9% | 3,719 | -2.8% | 0.08% | -1.2% |
| Q4 2015 | $154,000 | +28.3% | 3,827 | +22.7% | 0.08% | +18.1% |
| Q3 2015 | $120,000 | -32.6% | 3,119 | -27.2% | 0.07% | -32.7% |
| Q2 2015 | $178,000 | +26.2% | 4,284 | +40.2% | 0.11% | +18.9% |
| Q1 2015 | $141,000 | +7.6% | 3,055 | 0.0% | 0.09% | +4.7% |
| Q4 2014 | $131,000 | -14.4% | 3,055 | -8.3% | 0.09% | -15.7% |
| Q3 2014 | $153,000 | -6.1% | 3,330 | +9.0% | 0.10% | -13.6% |
| Q2 2014 | $163,000 | 0.0% | 3,055 | 0.0% | 0.12% | -3.3% |
| Q1 2014 | $163,000 | -50.0% | 3,055 | -50.0% | 0.12% | 0.0% |
| Q4 2013 | $326,000 | +113.1% | 6,110 | +100.0% | 0.12% | -0.8% |
| Q3 2013 | $153,000 | -3.2% | 3,055 | -3.1% | 0.12% | -8.9% |
| Q2 2013 | $158,000 | – | 3,153 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |